颈动脉内膜切除术后斑块病理评估的成本分析
单中心回顾性研究分析了40例颈动脉内膜切除术(CEA)患者的斑块病理评估成本与临床价值,发现病理报告与临床诊断相关性达100%,但未对术后临床决策产生影响;
要点
- 颈动脉斑块病理评估费用平均285美元,报销235美元,但无临床决策价值。
- 病理报告与临床诊断相关性100%,报告内容仅为动脉粥样硬化或钙化斑块。
核心结论
- 颈动脉斑块病理评估给医疗系统带来显著成本,但对术后患者管理无明确价值。
研究设计与样本
- 单中心回顾性研究,纳入2016至2019年接受CEA的患者,排除术后住院时间延长或术前卒中者,最终分析40例CEA。
主要发现
- 队列平均年龄67.2(±8.3)岁,72.5%入院时无症状,27.5%表现为短暂性脑缺血发作。
- 平均住院总费用83,367(±42,874)美元,其中专业费用3,512(±980)美元,设施费用80,395(±42,886)美元。
- 病理平均费用285(±88)美元,病理专业费用61(±27)美元,占专业费用的1.82%(±0.88)。
- 设施病理费用报销229(±57)美元,专业病理费用报销25(±14)美元。
- 所有斑块样本均行大体检查和HE染色,临床与病理诊断相关性100%,无基于病理报告的临床决策。
关键数值与推荐
- 病理报告仅描述「动脉粥样硬化斑块」占32.5%,「钙化斑块」占45%,另12.5%和10%分别注明纤维化和退行性变。
临床怎么用
- 应重新审视强制病理检查的医院政策及外科医生对斑块分析的个人偏好,避免低价值服务。
局限性
- 单中心回顾性设计,样本量较小(40例CEA),排除术后住院延长和术前卒中患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Overtreatment and overuse of resources are leading causes of rising health care costs. Identification and elimination process of low value services is important in reducing such costs. At many institutions it is routine to send excised plaque after carotid endarterectomy (CEA) for pathology evaluation. With more than 140,000 CEAs performed annually in the United States, this represents an opportunity for potential cost savings. We set out to examine the cost and clinical use of pathology evaluation of plaque after CEA. METHODS: We performed a retrospective review of patients undergoing CEA at a single institution from 2016 to 2019. Patients were excluded if they had a prolonged postoperative length of stay or if they had a preoperative stroke. Demographics, perioperative outcomes, and billing costs were recorded. RESULTS: We identified 82 total CEAs, of which 42 were excluded according to the aforementioned exclusion criteria. We reviewed 40 CEAs. Mean age of this cohort was 67.2 (±8.3) years. Most (72.5%) were asymptomatic at the time of admission, whereas 27.5% presented with a transient ischemic attack. Mean postoperative length of stay was 1.8 days. The primary insurers were 39.5% private, 39.5% Medicare, and 21.1% Medicaid. Mean total charges for the hospitalization were $83,367 (±$42,874). Of this total, professional fees were $3,512 (±$980) and facility fees were $80,395 (±$42,886). Mean pathology charges were $285 (±$88). The pathology professional fee was $61 (±$27), which represented 1.82% (±0.88) of the professional costs. Reimbursement for the facility pathology charge was $229 (±$57) and for the professional pathology charge was $25 (±$14). All plaque samples were submitted for gross examination and hematoxylin and eosin staining. The correlation rate for the clinical and pathologic diagnosis was 100%. The pathology reports simply read "atherosclerotic plaque" and "calcific plaque" in 32.5% and 45% of samples. For the remaining plaques, 12.5% and 10% of reports also noted fibrosis and degenerative changes, respectively. There were no clinical implications or decisions made based on the pathology reports. Cost of pathology evaluation was on average $285, with an average reimbursement of $235. With 140,000 CEAs done annually, this represents a potential $32.9-$39.9 million saved to the health care system. CONCLUSIONS: Pathology evaluation of carotid plaque incurs significant costs to the health care system with no clear value for the postoperative care of the patient. Hospital policy regarding mandatory pathologic examination and surgeon preferences regarding plaque analysis should be more closely examined.
引用
- Mendez L, Zhao Q, Elsadawi M, et al. A Cost Analysis of Pathology Evaluation of Carotid Plaque after Endarterectomy. Ann Vasc Surg. 2020. PMID: 32439530. doi:10.1016/j.avsg.2020.04.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。